pubmed-article:3678238 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:3678238 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:3678238 | lifeskim:mentions | umls-concept:C0003506 | lld:lifeskim |
pubmed-article:3678238 | lifeskim:mentions | umls-concept:C0009566 | lld:lifeskim |
pubmed-article:3678238 | lifeskim:mentions | umls-concept:C0175649 | lld:lifeskim |
pubmed-article:3678238 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
pubmed-article:3678238 | lifeskim:mentions | umls-concept:C1517942 | lld:lifeskim |
pubmed-article:3678238 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
pubmed-article:3678238 | pubmed:issue | 10 | lld:pubmed |
pubmed-article:3678238 | pubmed:dateCreated | 1988-1-21 | lld:pubmed |
pubmed-article:3678238 | pubmed:abstractText | A follow-up study was carried out in 54 patients after combined mitral and aortic valve replacement with the Lillehei-Kaster prosthesis. Twenty-two males and thirty-two females with a mean age of 54 years provided a total of 272 years of observation. The operative mortality was 16.7%. The long-term survival rates were 67% after 5 years and 55% after 8 years. The great majority of survivors showed a marked improvement in functional capacity and a significant decrease in heart volume. In spite of long-term anticoagulant treatment thromboembolic incidents were the most frequent valve-related complications. The percentage of patients free from valve-related morbidity and mortality was 75% after 8 years. Valve-related death accounted for 4% of all deaths. Fracture of the prosthesis was never encountered. These results compare favourably with those obtained with the Starr-Edwards' or the Björk-Shiley prostheses. | lld:pubmed |
pubmed-article:3678238 | pubmed:language | eng | lld:pubmed |
pubmed-article:3678238 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3678238 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:3678238 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:3678238 | pubmed:month | Oct | lld:pubmed |
pubmed-article:3678238 | pubmed:issn | 0195-668X | lld:pubmed |
pubmed-article:3678238 | pubmed:author | pubmed-author:NyboeJJ | lld:pubmed |
pubmed-article:3678238 | pubmed:author | pubmed-author:WennevoldAA | lld:pubmed |
pubmed-article:3678238 | pubmed:author | pubmed-author:OlesenK HKH | lld:pubmed |
pubmed-article:3678238 | pubmed:author | pubmed-author:RyggI HIH | lld:pubmed |
pubmed-article:3678238 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:3678238 | pubmed:volume | 8 | lld:pubmed |
pubmed-article:3678238 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:3678238 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:3678238 | pubmed:pagination | 1090-8 | lld:pubmed |
pubmed-article:3678238 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:3678238 | pubmed:meshHeading | pubmed-meshheading:3678238-... | lld:pubmed |
pubmed-article:3678238 | pubmed:meshHeading | pubmed-meshheading:3678238-... | lld:pubmed |
pubmed-article:3678238 | pubmed:meshHeading | pubmed-meshheading:3678238-... | lld:pubmed |
pubmed-article:3678238 | pubmed:meshHeading | pubmed-meshheading:3678238-... | lld:pubmed |
pubmed-article:3678238 | pubmed:meshHeading | pubmed-meshheading:3678238-... | lld:pubmed |
pubmed-article:3678238 | pubmed:meshHeading | pubmed-meshheading:3678238-... | lld:pubmed |
pubmed-article:3678238 | pubmed:meshHeading | pubmed-meshheading:3678238-... | lld:pubmed |
pubmed-article:3678238 | pubmed:meshHeading | pubmed-meshheading:3678238-... | lld:pubmed |
pubmed-article:3678238 | pubmed:meshHeading | pubmed-meshheading:3678238-... | lld:pubmed |
pubmed-article:3678238 | pubmed:meshHeading | pubmed-meshheading:3678238-... | lld:pubmed |
pubmed-article:3678238 | pubmed:meshHeading | pubmed-meshheading:3678238-... | lld:pubmed |
pubmed-article:3678238 | pubmed:meshHeading | pubmed-meshheading:3678238-... | lld:pubmed |
pubmed-article:3678238 | pubmed:year | 1987 | lld:pubmed |
pubmed-article:3678238 | pubmed:articleTitle | Long-term follow-up in 54 patients after combined mitral and aortic valve replacement with the Lillehei-Kaster prosthesis. Overall results and prosthesis-related complications. | lld:pubmed |
pubmed-article:3678238 | pubmed:affiliation | Department of Medicine B, Rigshospitalet, University of Copenhagen Medical School, Denmark. | lld:pubmed |
pubmed-article:3678238 | pubmed:publicationType | Journal Article | lld:pubmed |